2003
DOI: 10.1016/s0361-9230(03)00090-x
|View full text |Cite
|
Sign up to set email alerts
|

Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
32
0
1

Year Published

2004
2004
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(34 citation statements)
references
References 52 publications
1
32
0
1
Order By: Relevance
“…A recent study suggests that to be strictly relevant to TBI, levels in CSF must be measured, as serum levels are affected by nonnervous system sources. 11 In addition, another study has shown that serum levels of S-100B peak 2 days after CSF levels. 12 As with most new research areas in medicine, the initial work has been with small groups of patients, study designs differ, studies have not controlled for the same preexisting factors, and outcome has generally been measured within 6 months of injury.…”
Section: Clinical Interventions Serum Markersmentioning
confidence: 99%
“…A recent study suggests that to be strictly relevant to TBI, levels in CSF must be measured, as serum levels are affected by nonnervous system sources. 11 In addition, another study has shown that serum levels of S-100B peak 2 days after CSF levels. 12 As with most new research areas in medicine, the initial work has been with small groups of patients, study designs differ, studies have not controlled for the same preexisting factors, and outcome has generally been measured within 6 months of injury.…”
Section: Clinical Interventions Serum Markersmentioning
confidence: 99%
“…Unfortunately, owing to one or more limitations in sensitivity and specificity, none of these has emerged as a widely used diagnostic or prognostic clinical tool or a validated surrogate endpoint measure for irreversible brain damage. For example, although serum levels of S100β change in relation to short-term mortality and morbidity, as well as long-term neurologic outcome, the protein also markedly increases in serum during surgical procedures unrelated to acute brain injuries (Anderson et al, 2001;Routsi et al, 2006) as well as marathon runners (Hasselblatt et al, 2004), from which it is derived from adipose and other extracranial sources (Kleine et al, 2003). Furthermore, acute alterations in serum S100β are not consistently predictive of brain dysfunction resulting from mild brain injury (reviewed by Begaz et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Positive correlations between serum S100B levels with lymphocyte and granulocyte counts, both induced by cytokines, have been described in noninfectious acute care patients as well Kleine et al [23] but this was not assessed in this study.…”
Section: Discussionmentioning
confidence: 56%